WASHINGTON — AARP is urging seniors to review their Medicare plan options during this year’s Medicare Open Enrollment period. (October 15 – December 7, 2025) to determine the coverage that...

WASHINGTON - Beginning on April 14, the Social Security Administration assured AARP that they will allow all claim types to be completed over the telephone. This includes Retirement, Survivors,...

WASHINGTON — Today, AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement related to restructure plans announced by the U.S....

Today, AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement on the implementation of customer service changes announced by the Social Security Administration.

Today, AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement related to customer service changes announced by the Social Security Administration (SSA):

WASHINGTON—Today, AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement related to comments about changes at the Social Security Administration (SSA):

WASHINGTON — A new report out from AARP today provides additional insight into the impact of a historic new financial protection for our nation’s nearly 55 million Medicare drug plan enrollees. For the first time ever, beginning January 1, 2025, Medicare drug plans will limit enrollees’ annual out-of-pocket spending to $2,000, thanks to a provision in the 2022 Inflation Reduction Act that AARP championed. Specifically, the report shows that 94% of all Part D enrollees expected to reach the new cap in 2025 will have lower total (i.e., premiums and cost sharing) out-of-pocket costs, saving an average of $2,474 nationally. The report also provides state-level data and estimates that 95% of Part D enrollees who will reach the out-of-pocket cap will have lower out-of-pocket health costs in 33 states plus the District of Columbia.

According to a new AARP survey exploring the second half of life, most older adults have an optimistic outlook on life and expect their lives to improve as they get older. Nearly 9 in 10 are at least somewhat optimistic about their future, with half being extremely or very optimistic.

Today, AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services (CMS) announcement of the first Medicare negotiated drug prices as part of the 2022 prescription drug law:

AARP CEO Jo Ann Jenkins issued the following statement in response to the Medicare and Social Security Trustees Reports released today:

Today, AARP CEO Jo Ann Jenkins issued the following statement in response to President Biden’s State of the Union address:

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement today following the House Budget Committee vote approving fiscal commission proposals that include Social Security and Medicare

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services proposal to require federal minimum staffing levels in nursing homes.

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services’ list of the first 10 drugs to be negotiated for lower prices by Medicare.

List prices for the 25 brand-name drugs with the highest total Medicare Part D spending in 2021 have increased by an average of 226%—or more than tripled—since they first entered the market, a new report from AARP’s Public Policy Institute shows.

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services’ final implementation guidance of the Medicare Drug Price Negotiation Program.

AARP CEO Jo Ann Jenkins issued the following statement in response to the Medicare and Social Security Trustees’ reports released today.

AARP CEO Jo Ann Jenkins issued the following statement in response to President Biden’s State of the Union speech this evening

AARP CEO Jo Ann Jenkins issued the following statement on the importance of protecting Social Security and Medicare

AARP Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond issued the following statement on the Senate passage of the bipartisan 2023 omnibus bill. Earlier this month, AARP sent a letter to Congressional Leadership urging them to include important priorities for those age 50+ in any year-end legislative package.

The Centers for Medicare & Medicaid Services (CMS) released the 2023 premiums and deductibles for the Medicare Part B programs earlier today. Medicare Part B premiums will decrease by $5.20 to $164.90 next year, and deductibles will decrease $7 to $226. AARP had called for CMS to lower Part B premiums following a decline in the price and coverage of Aduhelm, which accounted for half of the premium increase in 2022.

AARP issued a statement from Jo Ann Jenkins, AARP Chief Executive Officer, after President Biden signed the Inflation Reduction Act of 2022.

AARP issued the following statement from Jo Ann Jenkins, AARP Chief Executive Officer, following the House passage of the Inflation Reduction Act of 2022

AARP issued the following statement from Jo Ann Jenkins, AARP Chief Executive Officer, following the Senate passage of the Inflation Reduction Act of 2022

AARP issued a statement from Nancy LeaMond, AARP Executive Vice President and Chief Advocacy and Engagement Officer, on the 57th anniversary of Medicare.

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to reports that the Senate reconciliation bill will extend the solvency of the Medicare program

AARP CEO Jo Ann Jenkins issued the following statement in response to the Medicare and Social Security Trustees’ reports released today

As members of Congress return to their districts for Easter recess, AARP is kicking off a new phase of its Fair Drug Prices Now campaign and pushing lawmakers to advance the prescription drug pricing provisions, including allowing Medicare to negotiate, already passed by the House, as a top priority when they return.

Today AARP launched new television and digital advertising featuring Larry Zarzecki, a retired law enforcement officer with Parkinson’s disease who was forced to sell his home in order to afford his medications. Zarzecki first shared his story in an AARP ad three years ago, but Congress’ failure to act means he has had no relief from the high cost of his treatments. As he says in the new ad, “I shouldn’t have to decide between my home or my medicine because Congress refuses to act. I’m tired of waiting for Congress.”

AARP CEO Jo Ann Jenkins released the following statement in response to President Biden’s State of the Union speech this evening, during which he called for action on high drug prices and announced new policies to improve nursing home care

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to President Biden’s remarks today about the need to lower prescription drug prices

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement about Medicare enrollees soon having access to at-home COVID tests at no cost:

AARP CEO Jo Ann Jenkins issued the following statement reacting to the announcement of a deal to lower prescription drug costs

AARP Chief Executive Officer Jo Ann Jenkins released the following statement in response to today’s announcement of the 2022 cost-of-living adjustment (COLA) in Social Security benefits

AARP has launched a full-scale campaign, including a $4 million ad buy, pushing back on false claims from the pharmaceutical industry that reforms would limit Americans’ access to medicines. AARP has called for fair drug prices for years and is urging Congress to pass legislation that would allow Medicare to negotiate drug prices, put a cap on out-of-pocket costs that older adults pay for their prescription drugs and impose penalties on drug companies that raise prices faster than the rate of inflation.

AARP CEO Jo Ann Jenkins issued the following statement in response to the Medicare and Social Security Trustees’ reports released today

An AARP survey released today finds that 85% of Americans age 50+ oppose cutting Social Security and Medicare to reduce the federal budget deficit.

Today AARP Georgia released a new survey of likely Georgia voters showing both U.S. Senate races statistically tied, with Democrat Jon Ossoff (48%) narrowly leading Republican incumbent David Perdue (46%) and Democrat Raphael Warnock (47%) edging Republican incumbent Kelly Loeffler (46%). But among voters age 50-plus, the poll shows both the Republican candidates lead their Democratic challenger by identical margins, 53% for Perdue and Loeffler versus 42% for Ossoff and Warnock.

WASHINGTON—Today AARP delivered a petition from 111,717 members, gathered in just two days, to the Postmaster General, calling for the suspension of any changes to mail delivery operations...

WASHINGTON—A new AARP survey, released in conjunction with Social Security’s 85th anniversary, confirms that Americans highly value Social Security, and even more so due to the pandemic. The...

WASHINGTON, DC—AARP today sent a letter to President Trump in response to his recent statements suggesting elimination of the current dedicated funding for Social Security. The full text of the...

WASHINGTON—AARP Executive Vice President Nancy LeaMond today made the following statement in response to President Trump’s executive order to suspend payroll taxes: “While we agree that...

WASHINGTON—Today AARP released a statement from Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond on the U.S. Supreme Court’s ruling on Title VII of the Civil Rights Act of 1964 and the federal health department’s rollback of key protections under Section 1557 of the Affordable Care Act (ACA):

WASHINGTON — AARP CEO Jo Ann Jenkins released the following statement in response to the Medicare and Social Security Trustees’ reports released today: “Medicare and Social Security are more...

WASHINGTON—AARP CEO Jo Ann Jenkins released the following statement on the bipartisan agreement on the coronavirus stimulus package, the Coronavirus Aid, Relief, and Economic Security (CARES)...

WASHINGTON—AARP released the following statement today on the bipartisan coronavirus package and House passage of HR 6201, the Families First Coronavirus Response Act. Said AARP Executive Vice...

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the White House’s FY2021 budget proposal: “AARP...

WASHINGTON—Today AARP released the findings of a nationwide poll that explores the priorities and concerns of a key group of voters that could help determine the 2020 presidential election and...

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement today in response to the Center for Medicare & Medicaid Services’ announcement on the increase in Medicare premiums and deductibles for 2020.

WASHINGTON—AARP released today its "AARP Asks the Candidates" video series featuring 17 presidential candidates and their plans to address high prescription drug prices, Medicare and Social...